Calidi Biotherapeutics (CLDI) Research & Development (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted Research & Development of $2.56 million for Q2 2026, down 1.3% from $2.59 million a year earlier.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Research & Development (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Calidi Biotherapeutics was $9.87 million, up 9.8% year-over-year; for FY2025, it was $9.74 million, up 9.7% from FY2024.
- Annual Research & Development shows a three-year compound annual growth rate of 10.3% (FY2022 to FY2025).
- In prior years, Calidi Biotherapeutics' Research & Development was $8.88 million in FY2024 (-31.7%), $13.01 million in FY2023 (+79.2%) and $7.26 million in FY2022.
- Quarterly Research & Development has run from a low of $1.82 million in Q4 2024 to a high of $3.96 million in Q4 2023 over five years.
- On a year-over-year basis, Research & Development increased in three of the last seven quarters, with an average decline of 5.9%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2023, with growth of 74.9%; the weakest was Q4 2024, with a decline of 54.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Calidi Biotherapeutics | 1.50 Mn | -23.88 Mn | - | 2.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.56 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | 2.59 Mn |
| Mar 31, 2025 | 2.43 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Mar 31, 2024 | 2.74 Mn |
| Dec 31, 2023 | 3.96 Mn |
| Sep 30, 2023 | 3.25 Mn |
| Jun 30, 2023 | 3.18 Mn |
| Mar 31, 2023 | 2.62 Mn |
| Dec 31, 2022 | 2.26 Mn |
| Sep 30, 2022 | 1.95 Mn |
API Access
Calidi Biotherapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CLDI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();